Literature DB >> 9548444

Globotriaosyl ceramide and globoside as major glycolipid components of fibroblasts in scirrhous gastric carcinoma tissues.

R Sawada1, H Hotta, Y S Chung, M Sowa, T Tai, I Yano.   

Abstract

Scirrhous gastric cancer is characteristic in that cancer cells proliferate and invade with prominent fibrosis. To search for the expression of specific carbohydrate chains in scirrhous gastric cancer, we have examined the glycosphingolipid composition of scirrhous cancer tissues (n=10) in comparison with that of non-scirrhous cancer tissues (n=10) by means of two-dimensional thin layer chromatography, followed by fast atom bombardment mass spectrometry of the individual glycolipids and immunostaining analysis. The major neutral glycosphingolipids from scirrhous gastric cancer tissues were identified as ceramide monohexoside, ceramide dihexoside, globotriaosyl ceramide (Gb3) and globoside (Gb4), while the major acidic glycosphingolipids were II3 NeuAcalpha-LacCer, II3 NeuAcalpha2-LacCer and sulfatide. Relative concentrations of Gb3 and Gb4 in scirrhous gastric cancer tissues (Gb3 + Gb4 = 58%) were two times higher than those in non-scirrhous gastric cancer tissues (29%). Orthotopic fibroblasts cloned from scirrhous gastric cancer tissues showed similar high concentrations of Gb3 and Gb4 to scirrhous gastric cancer tissues. Furthermore, immunohistochemical study revealed that Gb3 and Gb4 were expressed intensely on the fibroblasts. On the other hand, analysis of glycosphingolipids in four scirrhous gastric cancer cell lines yielded the following results. i) The contents of Gb3 and Gb4 were low (6%), compared with orthotopic fibroblasts (62%). ii) Significant amounts of Le(a) (pentaglycosylceramide) and Le(b) (hexa- and heptaglycosylceramides), which could not be detected in scirrhous cancer tissues, were observed. The results show that the major neutral glycosphingolipids such as Gb3 and Gb4 of scirrhous gastric cancer tissues were derived from orthotopic fibroblasts and not from the cancer cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9548444      PMCID: PMC5921761          DOI: 10.1111/j.1349-7006.1998.tb00545.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  32 in total

1.  Ganglioside pattern and neuraminic acid content of human gastric and colonic carcinoma.

Authors:  A Keränen; M Lempinen; K Puro
Journal:  Clin Chim Acta       Date:  1976-07-01       Impact factor: 3.786

2.  Incorporation of exogenous glycosphingolipids in plasma membranes of cultured hamster cells and concurrent change of growth behavior.

Authors:  R A Laine; S Hakomori
Journal:  Biochem Biophys Res Commun       Date:  1973-10-01       Impact factor: 3.575

3.  Glycosphingolipid composition of the gastric mucosa. A role of sulfatides in gastrointestinal mucosal defense?

Authors:  H Natomi; K Sugano; F Takaku; M Iwamori
Journal:  J Clin Gastroenterol       Date:  1990       Impact factor: 3.062

4.  Characterization of Lewis antigens in normal colon and gastrointestinal adenocarcinomas.

Authors:  M Blaszczyk; K Y Pak; M Herlyn; H F Sears; Z Steplewski
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

5.  Le(b), a novel glycosphingolipid antigen of human distal colorectal cancer.

Authors:  M Okuno; Y Chung; T Sogabe; M Sowa; H Hotta; I Yano
Journal:  Oncol Rep       Date:  1996-09       Impact factor: 3.906

6.  Generation of one set of murine monoclonal antibodies specific for globo-series glycolipids: evidence for differential distribution of the glycolipids in rat small intestine.

Authors:  M Kotani; I Kawashima; H Ozawa; K Ogura; T Ariga; T Tai
Journal:  Arch Biochem Biophys       Date:  1994-04       Impact factor: 4.013

7.  Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor.

Authors:  E G Bremer; J Schlessinger; S Hakomori
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

8.  New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3.

Authors:  R Kannagi; S B Levery; F Ishigami; S Hakomori; L H Shevinsky; B B Knowles; D Solter
Journal:  J Biol Chem       Date:  1983-07-25       Impact factor: 5.157

9.  Expression of Forssman glycolipid and blood group-related antigens A, Le(x), and Le(y) in human gastric cancer and in fetal tissues.

Authors:  K Uemura; H Hattori; K Ono; H Ogata; T Taketomi
Journal:  Jpn J Exp Med       Date:  1989-12

10.  Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination.

Authors:  M Yashiro; Y S Chung; S Nishimura; T Inoue; M Sowa
Journal:  Cancer       Date:  1996-04-15       Impact factor: 6.860

View more
  2 in total

1.  Shiga-like toxin I exerts specific and potent anti-tumour efficacy against gastric cancer cell proliferation when driven by tumour-preferential Frizzled-7 promoter.

Authors:  Hongpan Xu; Lijun Peng; Mengjiao Shen; Yanyan Xia; Zhiyang Li; Nongyue He
Journal:  Cell Prolif       Date:  2019-04-06       Impact factor: 6.831

2.  Fabry disease and incidence of cancer.

Authors:  Sarah Bird; Efthymios Hadjimichael; Atul Mehta; Uma Ramaswami; Derralynn Hughes
Journal:  Orphanet J Rare Dis       Date:  2017-09-06       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.